Numinus Wellness
Canadian mental health company offering ketamine-assisted therapy and psychedelic integration support, with an eye toward psilocybin-assisted therapy as regulatory frameworks evolve.
Type: therapy
Location: Vancouver, British Columbia (and US locations)
Membership: Patients and therapy clients
Venues: Clinics in Vancouver, Montreal, and US markets
Activities: Ketamine-assisted therapy (legal), preparation/integration therapy, psilocybin clinical trial participation
About
Numinus Wellness is a Vancouver-based mental health company that operates clinics offering ketamine-assisted therapy, psychedelic integration therapy, and a range of conventional mental health services. The company has positioned itself specifically for the transition to legal psilocybin-assisted therapy.
Numinus is one of the few publicly traded companies specifically in the psychedelic mental health space. It participated in the Canadian psilocybin exemption program for patients with serious conditions — an expanded access pathway that allowed some Canadians to access psilocybin outside of clinical trials.
Currently, the company's primary legal psychedelic therapy offering is ketamine-assisted therapy, which it provides at its clinic locations. It trains therapists in psychedelic-assisted therapy protocols and has established preparation and integration programs designed to be compatible with future psilocybin service models.
Numinus represents the emerging commercial mental health clinic model for psychedelic medicine — a company building infrastructure before full legalization that is positioned to offer psilocybin-assisted therapy quickly once regulatory pathways open.
Why It Matters
Numinus demonstrates what the emerging psilocybin therapy clinic infrastructure looks like — professional, clinical, regulated, and building expertise and scale ahead of broader regulatory access.
